亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项
Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.
Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?
ヌクレオチ(シ)ド類似物治療によって慢性B型肝炎の機能的治癒を達成している患者さんでも、HCCが発生する可能性があります。患者さんが肝臓疾患の進行を経験するかを予測するためには、どのようなツールがあるでしょうか?
HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.